- Home
- EVOK vs HSCS Comparison
EVOK vs HSCS Comparison
Compare EVOK & HSCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVOK
- HSCS
- Stock Information
- Founded
- EVOK 2007
- HSCS 2007
- Country
- EVOK United States
- HSCS United States
- Employees
- EVOK N/A
- HSCS N/A
- Industry
- EVOK Biotechnology: Pharmaceutical Preparations
- HSCS Medical Specialities
- Sector
- EVOK Health Care
- HSCS Health Care
- Exchange
- EVOK Nasdaq
- HSCS Nasdaq
- Market Cap
- EVOK 4.2M
- HSCS 3.7M
- IPO Year
- EVOK 2013
- HSCS 2022
- Fundamental
- Price
- EVOK $2.59
- HSCS $3.23
- Analyst Decision
- EVOK
- HSCS Strong Buy
- Analyst Count
- EVOK 0
- HSCS 2
- Target Price
- EVOK N/A
- HSCS $13.00
- AVG Volume (30 Days)
- EVOK 16.5K
- HSCS 10.2K
- Earning Date
- EVOK 05-13-2025
- HSCS 03-13-2025
- Dividend Yield
- EVOK N/A
- HSCS N/A
- EPS Growth
- EVOK N/A
- HSCS N/A
- EPS
- EVOK N/A
- HSCS N/A
- Revenue
- EVOK $10,249,415.00
- HSCS N/A
- Revenue This Year
- EVOK $58.84
- HSCS N/A
- Revenue Next Year
- EVOK $58.11
- HSCS N/A
- P/E Ratio
- EVOK N/A
- HSCS N/A
- Revenue Growth
- EVOK 97.84
- HSCS 261.17
- 52 Week Low
- EVOK $1.94
- HSCS $2.36
- 52 Week High
- EVOK $12.32
- HSCS $13.50
- Technical
- Relative Strength Index (RSI)
- EVOK 47.70
- HSCS 52.20
- Support Level
- EVOK $2.02
- HSCS $2.97
- Resistance Level
- EVOK $2.53
- HSCS $3.36
- Average True Range (ATR)
- EVOK 0.22
- HSCS 0.35
- MACD
- EVOK 0.10
- HSCS 0.03
- Stochastic Oscillator
- EVOK 97.01
- HSCS 50.41
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.